Case Report
Copyright ©The Author(s) 2022.
World J Clin Cases. Mar 16, 2022; 10(8): 2468-2473
Published online Mar 16, 2022. doi: 10.12998/wjcc.v10.i8.2468
Table 3 Reporting odds ratio of acute hepatitis and cholestasis in Vigibase® in patients receiving escitalopram

OR
95% CI
P value
Acute hepatitis1.9381.186-3.1660.0083
Cholestasis1.8661.279-2.7240.0012